EA202090069A1 - Композиция для применения в профилактике и лечении патологий сердечно-сосудистой системы - Google Patents
Композиция для применения в профилактике и лечении патологий сердечно-сосудистой системыInfo
- Publication number
- EA202090069A1 EA202090069A1 EA202090069A EA202090069A EA202090069A1 EA 202090069 A1 EA202090069 A1 EA 202090069A1 EA 202090069 A EA202090069 A EA 202090069A EA 202090069 A EA202090069 A EA 202090069A EA 202090069 A1 EA202090069 A1 EA 202090069A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- composition
- prevention
- cardiovascular system
- system pathologies
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000000748 cardiovascular system Anatomy 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1592—Iron
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/161—Magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/714—Vitamin K
- A23V2250/7144—Vitamin K2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000085412A IT201700085412A1 (it) | 2017-07-26 | 2017-07-26 | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
| PCT/IB2018/055586 WO2019021232A1 (en) | 2017-07-26 | 2018-07-26 | Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202090069A1 true EA202090069A1 (ru) | 2020-04-10 |
Family
ID=60451085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202090069A EA202090069A1 (ru) | 2017-07-26 | 2018-07-26 | Композиция для применения в профилактике и лечении патологий сердечно-сосудистой системы |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20200206157A1 (https=) |
| EP (1) | EP3657963A1 (https=) |
| JP (2) | JP2020528888A (https=) |
| KR (1) | KR20200032691A (https=) |
| CN (1) | CN111031813A (https=) |
| BR (1) | BR112020000902B1 (https=) |
| CA (1) | CA3070659A1 (https=) |
| CL (1) | CL2020000170A1 (https=) |
| CO (1) | CO2020000526A2 (https=) |
| EA (1) | EA202090069A1 (https=) |
| IL (1) | IL272138B2 (https=) |
| IT (1) | IT201700085412A1 (https=) |
| JO (1) | JOP20200012A1 (https=) |
| MA (1) | MA49794A (https=) |
| MX (1) | MX2020000806A (https=) |
| PE (1) | PE20200794A1 (https=) |
| PH (1) | PH12020550031A1 (https=) |
| WO (1) | WO2019021232A1 (https=) |
| ZA (1) | ZA202000461B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700089258A1 (it) | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| WO2019237054A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating calciphylaxis |
| MX2020013302A (es) | 2018-06-08 | 2021-05-12 | Epizon Pharma Inc | Métodos y composiciones para prevenir o tratar calcificación de tejido. |
| IT201900007326A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| IT201900007311A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| CN114748486A (zh) * | 2022-03-25 | 2022-07-15 | 南京盛德生物科技研究院有限公司 | 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用 |
| JP2025518284A (ja) | 2022-05-31 | 2025-06-12 | リージョン スイダンマーク | 冠動脈石灰化（ｃａｃ）の治療に使用するためのビタミンｋ２ |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3860849B2 (ja) * | 1994-04-28 | 2006-12-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗動脈硬化治療剤 |
| WO1996039053A2 (en) * | 1995-06-06 | 1996-12-12 | Campbell Soup Company | Mineral supplements for dietetic food |
| US6361800B1 (en) * | 2000-04-13 | 2002-03-26 | Cooper Concepts, Inc. | Multi-vitamin and mineral supplement |
| GB0220182D0 (en) * | 2002-08-30 | 2002-10-09 | Cardiovascular Res Inst Maastr | Organic compounds |
| CN101094681A (zh) * | 2003-10-28 | 2007-12-26 | 爱默蕾大学 | 透析液及其相关方法和系统 |
| US20050281888A1 (en) * | 2004-06-16 | 2005-12-22 | Chandra Ranjit K | Nutritional supplement for infants |
| WO2006055526A2 (en) * | 2004-11-16 | 2006-05-26 | Nu-Tein Co., Inc. | Compositions useful to treat ocular neovascular diseases and macular degeneration |
| BRPI0620425B8 (pt) * | 2005-12-23 | 2021-06-22 | Gupta Ajay | composição para nutrição parenteral, método para preparar a mesma, uso, e, kit |
| EP3066923B1 (en) * | 2006-01-30 | 2025-11-05 | Panion & BF Biotech Inc. | Method of treating chronic kidney disease |
| US20100021573A1 (en) * | 2008-07-22 | 2010-01-28 | Michael J Gonzalez | Compositions and methods for the prevention of cardiovascular disease |
| CN102159222B (zh) * | 2008-12-25 | 2014-08-06 | I.B.E.有限会社 | 生物活性剂，药物，化妆品，保鲜剂，以及植物以及动物的发育促进剂 |
| RU2606767C2 (ru) * | 2011-05-20 | 2017-01-10 | Фрисланд Брандз Б.В. | Композиция, содержащая витамин k2 |
| ITMI20121350A1 (it) * | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
| EP2886129A1 (en) * | 2013-12-20 | 2015-06-24 | VitaK B.V. | Prevention and counteraction of diet-induced thrombosis risk |
| EP3258924A2 (en) * | 2015-02-20 | 2017-12-27 | VitaK B.V. | Vitamin k and capillary function |
| US11344575B2 (en) * | 2016-08-15 | 2022-05-31 | Summit Innovation Labs, LLC | Vascular calcification prevention and treatment |
-
2017
- 2017-07-26 IT IT102017000085412A patent/IT201700085412A1/it unknown
-
2018
- 2018-07-26 JO JOP/2020/0012A patent/JOP20200012A1/ar unknown
- 2018-07-26 CN CN201880045110.6A patent/CN111031813A/zh active Pending
- 2018-07-26 MX MX2020000806A patent/MX2020000806A/es unknown
- 2018-07-26 MA MA049794A patent/MA49794A/fr unknown
- 2018-07-26 US US16/631,426 patent/US20200206157A1/en not_active Abandoned
- 2018-07-26 EP EP18762623.9A patent/EP3657963A1/en not_active Withdrawn
- 2018-07-26 PE PE2020000102A patent/PE20200794A1/es unknown
- 2018-07-26 CA CA3070659A patent/CA3070659A1/en active Pending
- 2018-07-26 WO PCT/IB2018/055586 patent/WO2019021232A1/en not_active Ceased
- 2018-07-26 IL IL272138A patent/IL272138B2/en unknown
- 2018-07-26 KR KR1020207001554A patent/KR20200032691A/ko not_active Ceased
- 2018-07-26 EA EA202090069A patent/EA202090069A1/ru unknown
- 2018-07-26 JP JP2020502672A patent/JP2020528888A/ja active Pending
- 2018-07-26 BR BR112020000902-4A patent/BR112020000902B1/pt not_active IP Right Cessation
-
2020
- 2020-01-17 CO CONC2020/0000526A patent/CO2020000526A2/es unknown
- 2020-01-17 PH PH12020550031A patent/PH12020550031A1/en unknown
- 2020-01-20 CL CL2020000170A patent/CL2020000170A1/es unknown
- 2020-01-23 ZA ZA2020/00461A patent/ZA202000461B/en unknown
-
2023
- 2023-05-02 JP JP2023076299A patent/JP2023090869A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019021232A1 (en) | 2019-01-31 |
| JOP20200012A1 (ar) | 2020-01-26 |
| JP2023090869A (ja) | 2023-06-29 |
| EP3657963A1 (en) | 2020-06-03 |
| IL272138B2 (en) | 2023-09-01 |
| CA3070659A1 (en) | 2019-01-31 |
| MX2020000806A (es) | 2020-08-17 |
| ZA202000461B (en) | 2021-03-31 |
| BR112020000902A2 (pt) | 2020-07-21 |
| JP2020528888A (ja) | 2020-10-01 |
| CO2020000526A2 (es) | 2020-02-18 |
| PE20200794A1 (es) | 2020-08-10 |
| MA49794A (fr) | 2020-06-03 |
| CN111031813A (zh) | 2020-04-17 |
| IL272138B1 (en) | 2023-05-01 |
| KR20200032691A (ko) | 2020-03-26 |
| IT201700085412A1 (it) | 2019-01-26 |
| US20200206157A1 (en) | 2020-07-02 |
| BR112020000902B1 (pt) | 2024-03-12 |
| IL272138A (en) | 2020-03-31 |
| PH12020550031A1 (en) | 2021-02-08 |
| CL2020000170A1 (es) | 2020-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202090069A1 (ru) | Композиция для применения в профилактике и лечении патологий сердечно-сосудистой системы | |
| PH12018502251A1 (en) | Formulations of an lsd1 inhibitor | |
| PH12017502079A1 (en) | Treatment of beta-thalassemia using actrii ligand traps | |
| MX2019003363A (es) | Composiciones farmaceuticas para usarse en la terapia de la blefaritis. | |
| EA201790998A1 (ru) | Иммуннорегуляторные агенты | |
| EA201691134A1 (ru) | Новые ингибиторы глутаминазы | |
| EA201691070A1 (ru) | Новые трициклические соединения в качестве противораковых средств | |
| EA201591591A1 (ru) | Соединения карбазола, применяемые в качестве ингибиторов бромодомена | |
| EA201890767A1 (ru) | C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений | |
| EA201891727A1 (ru) | Композиции на основе дейтерированного домперидона и способы терапии расстройств | |
| MX2020006237A (es) | Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4. | |
| MX2018003926A (es) | Composicion para mejorar el rendimiento. | |
| EA036102B9 (ru) | Терапевтические средства с углевод-опосредованной адресной доставкой | |
| MX2022001310A (es) | Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo. | |
| EA201500851A1 (ru) | ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3) | |
| EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
| EA202091020A1 (ru) | Замещенные имидазопиридинамиды и их применение | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
| EA201791009A1 (ru) | Композиции, содержащие циклоспорин | |
| EA201792401A1 (ru) | Композиции для очищения толстого кишечника и лечения желудочно-кишечных расстройств | |
| EA201500736A1 (ru) | Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов | |
| PH12016501548B1 (en) | Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases | |
| EA201691792A1 (ru) | Фармацевтические составы на основе вилдаглиптина | |
| EA201791525A2 (ru) | Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w |